Wang Lu, Chen Yan, Wei Qishan, Wu Yingxin, Huang Cuizhen, Liang Shanfeng, Steier Joerg, Catcheside Peter, Eckert Danny, Wellman Andrew, Luo Yuanming
State Key Laboratory of Respiratory Disease, Guangzhou Medical University, Guangzhou, China.
Guy's & St Thomas' NHS Foundation Trust and King's College London, London, UK.
Respirology. 2025 Aug;30(8):770-778. doi: 10.1111/resp.70037. Epub 2025 Mar 25.
Patient compliance with continuous positive airway pressure (CPAP) is similar using manual-titrated pressure compared to auto-titration, although auto-titration pressures are usually 2-5 cmHO higher than manual pressure, indicating that CPAP moderately higher than the optimal pressure will not necessarily impair compliance. We try to find the tolerable highest CPAP which does not increase respiratory effort based on changes in lung volume, diaphragm electromyography (EMG) and breathing sensations in healthy volunteers and OSA patients to simplify pressure titration.
Part 1, 12 healthy subjects and 16 OSA patients were enrolled in the measurement of expiratory reserve volume, diaphragm EMG, and expiratory muscle EMG at different CPAP levels. Breathing difficulty during different CPAP levels was assessed using a customised questionnaire in 35 healthy subjects and 33 OSA patients. Part 2, a two-night randomised crossover double-blind trial using the tolerable highest CPAP (10 cmHO) based on the results derived from Part 1 and the manually titrated pressure was performed in 25 OSA patients.
End expiratory lung volume increased significantly with increasing CPAP. In general, diaphragm EMG changed little when CPAP ≤ 10 cmHO. Expiratory muscle activity appeared when CPAP > 12 cmHO. There was no significant difference in subjective sensation of breathing difficulty with CPAP ≤ 10 cmHO. Sleep structure, AHI, and patient preference with 10 cmHO CPAP were not different from those under titrated pressure.
This study suggests that most patients with moderate to severe OSA can be effectively treated with CPAP at an initial pressure of 10 cmHO without pressure titration.
ClinicalTrials.gov identifier: NCT04925466.
尽管自动滴定压力通常比手动滴定压力高2 - 5 cmHO,但使用手动滴定压力时患者对持续气道正压通气(CPAP)的依从性与自动滴定相似,这表明略高于最佳压力的CPAP不一定会损害依从性。我们试图根据健康志愿者和阻塞性睡眠呼吸暂停(OSA)患者的肺容量变化、膈肌肌电图(EMG)和呼吸感觉,找出不会增加呼吸努力的可耐受最高CPAP,以简化压力滴定。
第一部分,12名健康受试者和16名OSA患者参与了不同CPAP水平下呼气储备量、膈肌EMG和呼气肌EMG的测量。在35名健康受试者和33名OSA患者中,使用定制问卷评估不同CPAP水平下的呼吸困难情况。第二部分,基于第一部分的结果,对25名OSA患者进行了为期两晚的随机交叉双盲试验,使用可耐受最高CPAP(10 cmHO)和手动滴定压力。
随着CPAP增加,呼气末肺容量显著增加。一般来说,当CPAP≤10 cmHO时,膈肌EMG变化不大。当CPAP>12 cmHO时,呼气肌活动出现。CPAP≤10 cmHO时,呼吸困难的主观感觉无显著差异。10 cmHO CPAP下的睡眠结构、呼吸暂停低通气指数(AHI)和患者偏好与滴定压力下无差异。
本研究表明,大多数中重度OSA患者在初始压力为10 cmHO的CPAP治疗下无需压力滴定即可得到有效治疗。
ClinicalTrials.gov标识符:NCT04925466。